speb/financial-data huggingface dataset:
PACS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 87045000.00
PACS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 568000.00
PACS cash_flow (annual, 2023-12-31) — Change In Payable: 33371000.00
PACS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 19771000.00
PACS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -18765000.00
PACS cash_flow (annual, 2023-12-31) — Change In Receivables: -179942000.00
PACS cash_flow (annual, 2023-12-31) — Change In Working Capital: -94661000.00
PACS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -176883000.00
PACS cash_flow (annual, 2023-12-31) — Changes In Cash: 20498000.00
PACS balance_sheet (annual, 2023-12-31) — Common Stock: 129000.00
PACS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -80394000.00
PACS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 96126000.00
PACS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2023-12-31) — Construction In Progress: 50937000.00
PACS income_statement (annual, 2023-12-31) — Cost Of Revenue: 2664424000.00
PACS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 188777000.00
PACS balance_sheet (annual, 2023-12-31) — Current Assets: 722147000.00
PACS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 110380000.00
PACS balance_sheet (annual, 2023-12-31) — Current Debt: 16822000.00
PACS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 127202000.00
PACS balance_sheet (annual, 2023-12-31) — Current Liabilities: 456926000.00
PACS cash_flow (annual, 2023-12-31) — Deferred Income Tax: -9923000.00
PACS cash_flow (annual, 2023-12-31) — Deferred Tax: -9923000.00
PACS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 25632000.00
PACS income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 25632000.00
PACS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 25632000.00
PACS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 25632000.00
PACS income_statement (annual, 2023-12-31) — Diluted Average Shares: 147773386.00
PACS income_statement (annual, 2023-12-31) — Diluted EPS: 0.76
PACS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 112874000.00
PACS cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 1862000.00
PACS balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 0.00
PACS income_statement (annual, 2023-12-31) — EBIT: 207236000.00
PACS income_statement (annual, 2023-12-31) — EBITDA: 232868000.00
PACS cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 391000.00
PACS cash_flow (annual, 2023-12-31) — End Cash Position: 118704000.00
PACS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 129592000.00
PACS cash_flow (annual, 2023-12-31) — Free Cash Flow: -109109000.00
PACS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
PACS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 581000.00
PACS income_statement (annual, 2023-12-31) — General And Administrative Expense: 213664000.00
PACS balance_sheet (annual, 2023-12-31) — Goodwill: 59021000.00
PACS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 65291000.00
PACS balance_sheet (annual, 2023-12-31) — Gross PPE: 2651140000.00
PACS income_statement (annual, 2023-12-31) — Gross Profit: 447068000.00
PACS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 60009000.00
PACS income_statement (annual, 2023-12-31) — Interest Expense: 49919000.00
PACS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 49919000.00
PACS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 50558000.00
PACS balance_sheet (annual, 2023-12-31) — Invested Capital: 828656000.00
PACS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -172791000.00
PACS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
PACS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1267017000.00
PACS balance_sheet (annual, 2023-12-31) — Land And Improvements: 55593000.00
PACS balance_sheet (annual, 2023-12-31) — Leases: 58958000.00
PACS balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
PACS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1961997000.00
PACS balance_sheet (annual, 2023-12-31) — Long Term Debt: 715708000.00
PACS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2677705000.00
PACS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1267017000.00
PACS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1057618000.00
PACS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 64750000.00
PACS balance_sheet (annual, 2023-12-31) — Minority Interest: 5600000.00
PACS income_statement (annual, 2023-12-31) — Minority Interests: -8000.00
PACS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -2597000.00
PACS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2023-12-31) — Net Debt: 659114000.00
PACS income_statement (annual, 2023-12-31) — Net Income: 112874000.00
PACS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 112874000.00
PACS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 112882000.00
PACS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 112874000.00
PACS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 112874000.00
PACS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 112882000.00
PACS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 112882000.00
PACS income_statement (annual, 2023-12-31) — Net Interest Income: -49919000.00
PACS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
PACS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 209399000.00
PACS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 209399000.00
PACS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -49919000.00
PACS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 587000.00
PACS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 750000.00
PACS balance_sheet (annual, 2023-12-31) — Net PPE: 2585340000.00
PACS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -172806000.00
PACS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 30835000.00
PACS balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 146167000.00
PACS balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
PACS income_statement (annual, 2023-12-31) — Normalized EBITDA: 232868000.00
PACS income_statement (annual, 2023-12-31) — Normalized Income: 112874000.00
PACS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 63697000.00
PACS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 391000.00
PACS income_statement (annual, 2023-12-31) — Operating Income: 207772000.00
PACS income_statement (annual, 2023-12-31) — Operating Revenue: 3110114000.00
PACS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 147773386.00
PACS balance_sheet (annual, 2023-12-31) — Other Current Assets: 48665000.00
PACS balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 16822000.00
PACS income_statement (annual, 2023-12-31) — Other Gand A: 213664000.00
PACS income_statement (annual, 2023-12-31) — Other Income Expense: -536000.00
PACS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6270000.00
PACS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 29376000.00
PACS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 139961000.00
PACS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 130215000.00
PACS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -536000.00
PACS balance_sheet (annual, 2023-12-31) — Other Properties: 2048348000.00
PACS balance_sheet (annual, 2023-12-31) — Other Receivables: 52259000.00
PACS balance_sheet (annual, 2023-12-31) — Payables: 140947000.00
PACS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 329724000.00
PACS income_statement (annual, 2023-12-31) — Pretax Income: 157317000.00
PACS balance_sheet (annual, 2023-12-31) — Properties: 0.00
PACS cash_flow (annual, 2023-12-31) — Purchase Of Business: -2597000.00
PACS cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
PACS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -172806000.00
PACS balance_sheet (annual, 2023-12-31) — Receivables: 600066000.00
PACS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2664424000.00
PACS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 25632000.00
PACS income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 216711000.00
PACS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1057618000.00
PACS balance_sheet (annual, 2023-12-31) — Retained Earnings: 95997000.00
PACS cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
PACS income_statement (annual, 2023-12-31) — Selling General And Administration: 213664000.00
PACS balance_sheet (annual, 2023-12-31) — Share Issued: 147773386.00
PACS income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
PACS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 0.00
PACS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 96126000.00
PACS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 30835000.00
PACS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (annual, 2023-12-31) — Tax Provision: 44435000.00
PACS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.28
PACS balance_sheet (annual, 2023-12-31) — Total Assets: 3512739000.00
PACS balance_sheet (annual, 2023-12-31) — Total Capitalization: 811834000.00
PACS balance_sheet (annual, 2023-12-31) — Total Debt: 2804907000.00
PACS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 101726000.00
PACS income_statement (annual, 2023-12-31) — Total Expenses: 2903720000.00
PACS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3411013000.00
PACS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2790592000.00
PACS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2954087000.00
PACS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 207772000.00
PACS income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
PACS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (annual, 2023-12-31) — Working Capital: 265221000.00
PACS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 153124371.00
PACS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.10
PACS cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 95285000.00
PACS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 158453331.00
PACS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.10
PACS cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 95285000.00
PACS cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 95285000.00
PACS cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
PACS income_statement (annual, 2024-12-31) — +Operating Expense: 384617000.00
PACS income_statement (annual, 2024-12-31) — +Total Revenue: 4089734000.00
PACS balance_sheet (annual, 2024-12-31) — Accounts Payable: 175062000.00
PACS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 641775000.00
PACS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -105719000.00
PACS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 591363000.00
PACS income_statement (annual, 2024-12-31) — Basic Average Shares: 146663371.00
PACS income_statement (annual, 2024-12-31) — Basic EPS: 0.38
PACS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 118704000.00
PACS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 654975000.00
PACS cash_flow (annual, 2024-12-31) — Capital Expenditure: -349809000.00
PACS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3093182000.00
PACS balance_sheet (annual, 2024-12-31) — Capital Stock: 155000.00
PACS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 157674000.00
PACS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 157674000.00
PACS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -33721000.00
PACS cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
PACS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 117476000.00
PACS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -442679000.00
PACS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 367341000.00
PACS cash_flow (annual, 2024-12-31) — Change In Account Payable: 33398000.00
PACS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 192493000.00
PACS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -13338000.00
PACS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 88801000.00
PACS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -9473000.00
PACS cash_flow (annual, 2024-12-31) — Change In Payable: 33398000.00
PACS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 225891000.00
PACS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -17210000.00
PACS cash_flow (annual, 2024-12-31) — Change In Receivables: -116455000.00
PACS cash_flow (annual, 2024-12-31) — Change In Working Capital: 158216000.00
PACS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -93968000.00
PACS cash_flow (annual, 2024-12-31) — Changes In Cash: 42138000.00
PACS balance_sheet (annual, 2024-12-31) — Common Stock: 155000.00
PACS cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -33721000.00
PACS cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
PACS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 709554000.00
PACS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 509442000.00
PACS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2024-12-31) — Construction In Progress: 23952000.00
PACS income_statement (annual, 2024-12-31) — Cost Of Revenue: 3582044000.00
PACS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 343314000.00
PACS balance_sheet (annual, 2024-12-31) — Current Assets: 938261000.00
PACS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 157409000.00
PACS balance_sheet (annual, 2024-12-31) — Current Debt: 156852000.00
PACS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 314261000.00
PACS balance_sheet (annual, 2024-12-31) — Current Liabilities: 978432000.00
PACS balance_sheet (annual, 2024-12-31) — Current Provisions: 145795000.00
PACS cash_flow (annual, 2024-12-31) — Deferred Income Tax: -44484000.00
PACS cash_flow (annual, 2024-12-31) — Deferred Tax: -44484000.00
PACS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 40809000.00
PACS income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 40809000.00
PACS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 40809000.00
PACS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 40809000.00
PACS income_statement (annual, 2024-12-31) — Diluted Average Shares: 148574606.00
PACS income_statement (annual, 2024-12-31) — Diluted EPS: 0.38
PACS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 55760000.00
PACS cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 3521000.00
PACS income_statement (annual, 2024-12-31) — EBIT: 145895000.00
PACS income_statement (annual, 2024-12-31) — EBITDA: 186704000.00
PACS cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 4565000.00
PACS cash_flow (annual, 2024-12-31) — End Cash Position: 160842000.00
PACS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 117476000.00
PACS cash_flow (annual, 2024-12-31) — Free Cash Flow: 17532000.00
PACS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1258000.00
PACS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -1258000.00
PACS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 843000.00
PACS income_statement (annual, 2024-12-31) — General And Administrative Expense: 343808000.00
PACS balance_sheet (annual, 2024-12-31) — Goodwill: 60791000.00
PACS balance_sheet (quarterly, 2024-12-31) — Goodwill: 60791000.00
PACS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 67061000.00
PACS balance_sheet (annual, 2024-12-31) — Gross PPE: 4090818000.00
PACS income_statement (annual, 2024-12-31) — Gross Profit: 507690000.00
PACS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 107831000.00
PACS income_statement (annual, 2024-12-31) — Interest Expense: 44341000.00
PACS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 44341000.00
PACS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 48248000.00
PACS balance_sheet (annual, 2024-12-31) — Invested Capital: 1117390000.00
PACS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -442679000.00
PACS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 509442000.00
PACS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
PACS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 748305000.00
PACS balance_sheet (annual, 2024-12-31) — Land And Improvements: 84774000.00
PACS balance_sheet (annual, 2024-12-31) — Leases: 79440000.00
PACS balance_sheet (annual, 2024-12-31) — Line Of Credit: 142000000.00
PACS balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 142000000.00
PACS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2935773000.00
PACS balance_sheet (annual, 2024-12-31) — Long Term Debt: 250984000.00
PACS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3186757000.00
PACS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 748305000.00
PACS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1073455000.00
PACS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 107896000.00
PACS balance_sheet (annual, 2024-12-31) — Minority Interest: 6137000.00
PACS income_statement (annual, 2024-12-31) — Minority Interests: 416000.00
PACS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -32891000.00
PACS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -2465000.00
PACS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 509442000.00
PACS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2024-12-31) — Net Debt: 250162000.00
PACS balance_sheet (quarterly, 2024-12-31) — Net Debt: 250162000.00
PACS income_statement (annual, 2024-12-31) — Net Income: 55760000.00
PACS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 55760000.00
PACS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 55344000.00
PACS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 55760000.00
PACS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 55760000.00
PACS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 55344000.00
PACS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 55344000.00
PACS income_statement (annual, 2024-12-31) — Net Interest Income: -44341000.00
PACS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -65000000.00
PACS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -325150000.00
PACS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -325150000.00
PACS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -44341000.00
PACS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -33095000.00
PACS cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 1000.00
PACS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1500000.00
PACS cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
PACS balance_sheet (annual, 2024-12-31) — Net PPE: 3985099000.00
PACS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -349809000.00
PACS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 642493000.00
PACS balance_sheet (annual, 2024-12-31) — Non Current Accrued Expenses: 164979000.00
PACS balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 66258000.00
PACS income_statement (annual, 2024-12-31) — Normalized EBITDA: 178658000.00
PACS income_statement (annual, 2024-12-31) — Normalized Income: 49403660.00
PACS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 367341000.00
PACS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 3307000.00
PACS income_statement (annual, 2024-12-31) — Operating Income: 123073000.00
PACS income_statement (annual, 2024-12-31) — Operating Revenue: 4086655000.00
PACS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 155177511.00
PACS balance_sheet (annual, 2024-12-31) — Other Current Assets: 64066000.00
PACS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 14852000.00
PACS income_statement (annual, 2024-12-31) — Other Gand A: 343808000.00
PACS income_statement (annual, 2024-12-31) — Other Income Expense: 22822000.00
PACS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 6270000.00
PACS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 6270000.00
PACS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 38605000.00
PACS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 186230000.00
PACS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 197050000.00
PACS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 14776000.00
PACS balance_sheet (annual, 2024-12-31) — Other Properties: 3139781000.00
PACS balance_sheet (annual, 2024-12-31) — Other Receivables: 74746000.00
PACS income_statement (annual, 2024-12-31) — Other Special Charges: -8046000.00
PACS income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
PACS balance_sheet (annual, 2024-12-31) — Payables: 175062000.00
PACS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 518376000.00
PACS income_statement (annual, 2024-12-31) — Pretax Income: 101554000.00
PACS balance_sheet (annual, 2024-12-31) — Properties: 0.00
PACS cash_flow (annual, 2024-12-31) — Purchase Of Business: -32891000.00
PACS cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -2465000.00
PACS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -90874000.00
PACS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -349809000.00
PACS balance_sheet (annual, 2024-12-31) — Receivables: 716521000.00
PACS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3582044000.00
PACS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 40809000.00
PACS income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 284953000.00
PACS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1073455000.00
PACS balance_sheet (annual, 2024-12-31) — Retained Earnings: 118036000.00
PACS cash_flow (annual, 2024-12-31) — Sale Of Investment: 25874000.00
PACS income_statement (annual, 2024-12-31) — Selling General And Administration: 343808000.00
PACS balance_sheet (annual, 2024-12-31) — Share Issued: 155177511.00
PACS income_statement (annual, 2024-12-31) — Special Income Charges: 8046000.00
PACS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
PACS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 115544000.00
PACS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 709554000.00
PACS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 642493000.00
PACS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1689660.00
PACS income_statement (annual, 2024-12-31) — Tax Provision: 46210000.00
PACS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
PACS balance_sheet (annual, 2024-12-31) — Total Assets: 5242909000.00
PACS balance_sheet (annual, 2024-12-31) — Total Capitalization: 960538000.00
PACS balance_sheet (annual, 2024-12-31) — Total Debt: 3501018000.00
PACS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 715691000.00
PACS income_statement (annual, 2024-12-31) — Total Expenses: 3966661000.00
PACS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4527218000.00
PACS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4304648000.00
PACS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3548786000.00
PACS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 123073000.00
PACS income_statement (annual, 2024-12-31) — Total Unusual Items: 8046000.00
PACS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
PACS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 8046000.00
PACS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (annual, 2024-12-31) — Working Capital: -40171000.00
PACS income_statement (quarterly, 2025-03-31) — +Operating Expense: 111424000.00
PACS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1277150000.00
PACS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 198617000.00
PACS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 680676000.00
PACS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -118136000.00
PACS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 603565000.00
PACS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 155177511.00
PACS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.18
PACS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 160842000.00
PACS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 660533000.00
PACS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -17717000.00
PACS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3165760000.00
PACS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 155000.00
PACS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 287512000.00
PACS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 287512000.00
PACS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4065000.00
PACS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -16416000.00
PACS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 150244000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 20606000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 104950000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -3833000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -7254000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 3312000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Payable: 20606000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 125556000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 11800000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -25180000.00
PACS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 104401000.00
PACS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -38901000.00
PACS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 129763000.00
PACS balance_sheet (quarterly, 2025-03-31) — Common Stock: 155000.00
PACS cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
PACS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 750228000.00
PACS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 31154000.00
PACS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1117586000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 450063000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1081404000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 141620000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Debt: 154959000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 296579000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1107413000.00
PACS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 162154000.00
PACS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -19580000.00
PACS cash_flow (quarterly, 2025-03-31) — Deferred Tax: -19580000.00
PACS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 12705000.00
PACS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 12705000.00
PACS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 12705000.00
PACS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 12705000.00
PACS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 166415616.00
PACS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.17
PACS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 28472000.00
PACS cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 1301000.00
PACS income_statement (quarterly, 2025-03-31) — EBIT: 49634000.00
PACS income_statement (quarterly, 2025-03-31) — EBITDA: 62339000.00
PACS cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 298000.00
PACS cash_flow (quarterly, 2025-03-31) — End Cash Position: 290605000.00
PACS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4065000.00
PACS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 132527000.00
PACS cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -1652000.00
PACS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 98719000.00
PACS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 67061000.00
PACS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4192184000.00
PACS income_statement (quarterly, 2025-03-31) — Gross Profit: 159564000.00
PACS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 357000.00
PACS income_statement (quarterly, 2025-03-31) — Interest Expense: 6904000.00
PACS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6904000.00
PACS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 8085000.00
PACS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1154276000.00
PACS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -16416000.00
PACS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
PACS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 84774000.00
PACS balance_sheet (quarterly, 2025-03-31) — Leases: 83298000.00
PACS balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 142000000.00
PACS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3024140000.00
PACS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 249089000.00
PACS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3273229000.00
PACS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -4065000.00
PACS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 111656000.00
PACS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 6045000.00
PACS income_statement (quarterly, 2025-03-31) — Minority Interests: 92000.00
PACS cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
PACS balance_sheet (quarterly, 2025-03-31) — Net Debt: 116536000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income: 28472000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 28472000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 28380000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 28472000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 28472000.00
PACS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 28380000.00
PACS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 28380000.00
PACS income_statement (quarterly, 2025-03-31) — Net Interest Income: -6904000.00
PACS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4065000.00
PACS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -4065000.00
PACS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6904000.00
PACS balance_sheet (quarterly, 2025-03-31) — Net PPE: 4074048000.00
PACS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -17717000.00
PACS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 683167000.00
PACS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 186705000.00
PACS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 67910000.00
PACS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 62339000.00
PACS income_statement (quarterly, 2025-03-31) — Normalized Income: 28472000.00
PACS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 150244000.00
PACS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1354000.00
PACS income_statement (quarterly, 2025-03-31) — Operating Income: 48140000.00
PACS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1276985000.00
PACS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 155177511.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 52191000.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 12959000.00
PACS income_statement (quarterly, 2025-03-31) — Other Gand A: 98719000.00
PACS income_statement (quarterly, 2025-03-31) — Other Income Expense: 1494000.00
PACS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 13490000.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 203977000.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 170780000.00
PACS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1494000.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3220769000.00
PACS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 61025000.00
PACS balance_sheet (quarterly, 2025-03-31) — Payables: 198617000.00
PACS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 648680000.00
PACS income_statement (quarterly, 2025-03-31) — Pretax Income: 42730000.00
PACS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -17717000.00
PACS balance_sheet (quarterly, 2025-03-31) — Receivables: 741701000.00
PACS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1117586000.00
PACS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12705000.00
PACS income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 93795000.00
PACS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4065000.00
PACS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 146508000.00
PACS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 98719000.00
PACS balance_sheet (quarterly, 2025-03-31) — Share Issued: 155177511.00
PACS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
PACS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12202000.00
PACS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 750228000.00
PACS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 683167000.00
PACS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (quarterly, 2025-03-31) — Tax Provision: 14350000.00
PACS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.34
PACS balance_sheet (quarterly, 2025-03-31) — Total Assets: 5494400000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 999317000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Debt: 3569808000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 756273000.00
PACS income_statement (quarterly, 2025-03-31) — Total Expenses: 1229010000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4738127000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4412996000.00
PACS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3630714000.00
PACS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 48140000.00
PACS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
PACS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (quarterly, 2025-03-31) — Working Capital: -26009000.00
PACS income_statement (quarterly, 2025-06-30) — +Operating Expense: 113510000.00
PACS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1309236000.00
PACS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 172023000.00
PACS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 638127000.00
PACS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -131005000.00
PACS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 609212000.00
PACS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 156335230.00
PACS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.33
PACS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 290605000.00
PACS balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 664093000.00
PACS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -18815000.00
PACS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3136449000.00
PACS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 157000.00
PACS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 294173000.00
PACS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 294173000.00
PACS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
PACS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -13132000.00
PACS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -32405000.00
PACS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 52574000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -25346000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 95027000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -10693000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -113465000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1596000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Payable: -25346000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 69681000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -35636000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 51929000.00
PACS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -39780000.00
PACS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 42549000.00
PACS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 7037000.00
PACS balance_sheet (quarterly, 2025-06-30) — Common Stock: 157000.00
PACS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: 0.00
PACS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 806840000.00
PACS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 26001000.00
PACS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1115227000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 524426000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Assets: 1077221000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 145041000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Debt: 152146000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 297187000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1167231000.00
PACS balance_sheet (quarterly, 2025-06-30) — Current Provisions: 173595000.00
PACS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 2551000.00
PACS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 2551000.00
PACS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 13178000.00
PACS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 13178000.00
PACS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13178000.00
PACS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 13178000.00
PACS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 165474133.00
PACS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.31
PACS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 50963000.00
PACS cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 1521000.00
PACS income_statement (quarterly, 2025-06-30) — EBIT: 82966000.00
PACS income_statement (quarterly, 2025-06-30) — EBITDA: 96144000.00
PACS cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 14000.00
PACS cash_flow (quarterly, 2025-06-30) — End Cash Position: 297642000.00
PACS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -13132000.00
PACS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 33759000.00
PACS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: -1212000.00
PACS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 100332000.00
PACS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 67061000.00
PACS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4198307000.00
PACS income_statement (quarterly, 2025-06-30) — Gross Profit: 194009000.00
PACS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 80062000.00
PACS income_statement (quarterly, 2025-06-30) — Interest Expense: 4354000.00
PACS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4354000.00
PACS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 9874000.00
PACS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1205978000.00
PACS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -32405000.00
PACS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
PACS balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 84774000.00
PACS balance_sheet (quarterly, 2025-06-30) — Leases: 96286000.00
PACS balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 142000000.00
PACS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2991408000.00
PACS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 246992000.00
PACS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3238400000.00
PACS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
PACS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4957000.00
PACS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 117464000.00
PACS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 5828000.00
PACS income_statement (quarterly, 2025-06-30) — Minority Interests: -3000.00
PACS cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
PACS balance_sheet (quarterly, 2025-06-30) — Net Debt: 104965000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income: 50963000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 50963000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 50966000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 50963000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 50963000.00
PACS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 50966000.00
PACS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 50966000.00
PACS income_statement (quarterly, 2025-06-30) — Net Interest Income: -4354000.00
PACS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -15111000.00
PACS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -4957000.00
PACS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -4957000.00
PACS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4354000.00
PACS balance_sheet (quarterly, 2025-06-30) — Net PPE: 4067302000.00
PACS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -18815000.00
PACS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 739779000.00
PACS balance_sheet (quarterly, 2025-06-30) — Non Current Accrued Expenses: 207635000.00
PACS balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 79159000.00
PACS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 96144000.00
PACS income_statement (quarterly, 2025-06-30) — Normalized Income: 50963000.00
PACS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 52574000.00
PACS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1198000.00
PACS income_statement (quarterly, 2025-06-30) — Operating Income: 80499000.00
PACS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1308881000.00
PACS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 156569693.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 93276000.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 10146000.00
PACS income_statement (quarterly, 2025-06-30) — Other Gand A: 100332000.00
PACS income_statement (quarterly, 2025-06-30) — Other Income Expense: 2467000.00
PACS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 13253000.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 211426000.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 76235000.00
PACS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2467000.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Properties: 3209689000.00
PACS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 51645000.00
PACS balance_sheet (quarterly, 2025-06-30) — Payables: 172023000.00
PACS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 696449000.00
PACS income_statement (quarterly, 2025-06-30) — Pretax Income: 78612000.00
PACS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PACS cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
PACS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -15111000.00
PACS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -18815000.00
PACS balance_sheet (quarterly, 2025-06-30) — Receivables: 689772000.00
PACS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1115227000.00
PACS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13178000.00
PACS income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 94348000.00
PACS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4957000.00
PACS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 197471000.00